I think if you strip out the $1.2m (net of tax) of IPO cost in FY22 then the FY23 EBIT of about $23m is more like a rise of 26%, still not to be scoffed at under any circumstance.
Growth in EBIT has slowed in 2H23 to about 20% on pcp, from the 34% in 1H23 on pcp, so maybe this didn't meet lofty market expectations and there was a sell-off today, who knows?
Pleasingly management talk remains very positive regarding the outlook, fingers crossed they can keep executing well.
I think if you strip out the $1.2m (net of tax) of IPO cost in...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
